StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $12.64 | $12.31 | -2.61% | 0.6M |
| 05-12 | $12.14 | $12.64 | +4.12% | 1.0M |
| 05-13 | $12.59 | $12.19 | -3.18% | 0.8M |
| 05-14 | $11.91 | $12.77 | +7.22% | 1.1M |
| 05-15 | $12.36 | $11.64 | -5.83% | 0.4M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
No sell-side coverage available for CLPT.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for CLPT.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.13M | $36.97M | $26.56M | $17.70M |
Operating Income | $-8.48M | $-24.16M | $-17.12M | $-11.84M |
Net Income | $-9.55M | $-25.54M | $-17.75M | $-5.84M |
EPS (Diluted) | $-0.32 | $-0.90 | $-0.63 | $-0.42 |
Total Assets | $93.42M | $97.75M | $60.36M | $62.87M |
Total Liabilities | $74.58M | $69.73M | $44.48M | $43.13M |
Cash & Equivalents | $35.59M | $45.92M | $38.22M | $41.54M |
Free Cash Flow OCF − CapEx | $-8.61M | $-24.42M | $-12.32M | $-9.00M |
Shares Outstanding | 29.99M | 29.37M | 28.43M | 28.42M |
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.